JPMorgan Strategists Say Equities Are Flashing a Bullish Signal

image

(Bloomberg) — Stock markets are flashing a bullish signal amid tentative signs that inflation volatility is peaking, according to JPMorgan Chase & Co. strategists.

As fears about hawkish central banks and a potential recession sparked a rout in US stock markets this year, the put to call open interest of S&P 500 options collapsed as demand for hedging subsided, strategists led by Nikolaos Panigirtzoglou wrote in a note on Wednesday.

“This reduced demand for hedging equity risk is a bullish signal as it likely reflects low equity positioning by investors,” they said. “There are some tentative signs that inflation volatility could be peaking, which would be consistent with markets continuing to look through the spike.”

Panigirtzoglou said this implies a fair value of 4,400 index points for the S&P 500 in the second quarter — an upside of about 7% from current levels. In an adverse scenario, which assumes that markets start to factor in a rise in inflation volatility, the fair value falls to 3,350 points, the strategist said.

The call by Panigirtzoglou, a widely followed expert on Wall Street capital flows, comes just weeks after the S&P 500 flirted with a bear market as the Federal Reserve embarked on an aggressive rate-hiking path, fueling fears about a recession amid surging inflation. Although stocks have since tried to recover, a jump in bond yields above the key 3% level has kept risk demand subdued.

Strategists are divided on whether the stock rout has found a floor, with the likes of Morgan Stanley’s Michael Wilson forecasting that the US benchmark will trade close to 3,400 index points by mid-to-late August, implying another 17% downside from its latest close.

On Monday, JPMorgan strategists including Mislav Matejka reiterated their bullish view on stocks, saying “the fundamental risk-reward for equities is likely improving as we approach the second half of the year.”

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More